Download Sample
Add to CartGlobal Veterinary Vaccines Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Porcine, Poultry, Livestock, and Companion AnimalsBy Technology;
Live Attenuated, Inactivated, and ToxoidBy Disease Indication;
Foot & Mouth Disease (FMD), Newcastle Disease, Porcine Reproductive & Respiratory Syndrome (PRRS), Canine Parvovirus, Brucellosis, Avian Influenza, and OthersBy Distribution Channel;
Veterinary Hospital Pharmacies, Veterinary Clinics, Retail Pharmacies, and Online PharmaciesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Veterinary Vaccines Market Overview
Veterinary Vaccines Market (USD Million)
Veterinary Vaccines Market was valued at USD 9,442.65 million in the year 2024. The size of this market is expected to increase to USD 14,712.38 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.5%.
Global Veterinary Vaccines Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 6.5 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.5 % |
| Market Size (2024) | USD 9,442.65 Million |
| Market Size (2031) | USD 14,712.38 Million |
| Market Concentration | Medium |
| Report Pages | 355 |
Major Players
- Zoetis Inc
- Merck & Co Inc
- Boehringer Ingelheim International GmbH
- Elanco Animal Health
- Virbac
- Ceva Santé Animale
- Phibro Animal Health Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Veterinary Vaccines Market
Fragmented - Highly competitive market without dominant players
The Veterinary Vaccines Market is gaining momentum due to rising awareness about preventive animal healthcare. Vaccinations are a cornerstone of efforts to prevent the spread of diseases in both pets and livestock. Presently, over 55% of animal care initiatives center on vaccination, underscoring their vital role in modern veterinary practices. This trend is being fueled by stronger awareness among both pet owners and agricultural producers.
Livestock Immunization for Better Yields
Vaccines are also transforming livestock management, with a growing number of farms using them to improve health and productivity. Structured vaccination plans are implemented by over 65% of livestock producers, leading to fewer disease outbreaks and more stable yields.
Innovation in Veterinary Vaccines
Cutting-edge advancements in the form of recombinant and DNA-based vaccines are reshaping the market. Approximately 40% of the latest veterinary innovations focus on vaccines, driven by their effectiveness and user-friendly formats. These technologies are making immunization more efficient, longer-lasting, and safer, thus improving uptake across the veterinary ecosystem.
Government Support Driving Adoption
Governmental backing is accelerating vaccine accessibility and usage through public veterinary health initiatives. More than 50% of such programs incorporate subsidized or mandatory vaccinations. This is strengthening disease control efforts and encouraging the development of infrastructure and research that supports long-term market growth.
Veterinary Vaccines Market Recent Developments
-
In September 2022, Zoetis acquired Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.
-
In June 2022, Boehringer Ingelheim and CarthroniX partnered to pursue small molecule therapeutics in canine oncology.
Veterinary Vaccines Market Segment Analysis
In this report, the Veterinary Vaccines Market has been segmented by Type, Technology, Disease Indication, Distribution Channel and Geography.
Veterinary Vaccines Market, Segmentation by Type
The Veterinary Vaccines Market has been segmented by Type into Porcine, Poultry, Livestock and Companion Animals.
Porcine
Porcine vaccines contribute approximately 26% of the global veterinary vaccines market revenue in 2022. These vaccines play a crucial role in preventing swine diseases such as porcine reproductive and respiratory syndrome (PRRS) and classical swine fever. Rising global pork production and increasing focus on swine health management support growth in this segment.
Poultry
Poultry vaccines dominate the veterinary vaccines market, contributing around 37% of global revenue. They are essential for controlling diseases such as Newcastle disease, avian influenza, and infectious bronchitis. The rising demand for poultry meat and eggs and increasing adoption of preventive healthcare drive strong growth.
Livestock
Livestock vaccines hold an estimated 22% share of the global veterinary vaccines market. This segment includes vaccines for cattle, sheep, and goats, addressing diseases like foot-and-mouth disease and bovine respiratory disease. Growing meat and dairy consumption and rising awareness of livestock health support expansion.
Companion Animals
Companion animal vaccines account for around 15% of global veterinary vaccines market revenue. These vaccines help protect dogs, cats, and other pets against rabies, canine distemper, and feline leukemia. The rising trend of pet ownership and increasing expenditure on pet healthcare fuel growth.
Veterinary Vaccines Market, Segmentation by Technology
The Veterinary Vaccines Market has been segmented by Technology into Live Attenuated, Inactivated and Toxoid.
Live Attenuated
Live Attenuated vaccines dominate the veterinary vaccines market, contributing approximately 45% of global revenue in 2022. These vaccines use weakened pathogens to induce strong and long-lasting immune responses. Their effectiveness in controlling infectious diseases in livestock and poultry supports strong demand.
Inactivated
Inactivated vaccines hold an estimated 38% share of the global veterinary vaccines market. These vaccines use killed pathogens to provide safe and effective disease prevention, especially in companion animals and certain livestock species. Increasing focus on animal safety and rising pet vaccination rates fuel growth.
Toxoid
Toxoid vaccines account for around 17% of global veterinary vaccines market revenue. These vaccines use inactivated toxins to protect against bacterial diseases such as tetanus and clostridial infections. Their role in livestock health management and growing use in herd immunization programs support market growth.
Veterinary Vaccines Market, Segmentation by Disease Indication
The Veterinary Vaccines Market has been segmented by Disease Indication into Foot & Mouth Disease (FMD), Newcastle Disease, Porcine Reproductive & Respiratory Syndrome (PRRS), Canine Parvovirus, Brucellosis, Avian Influenza and Others.
Foot & Mouth Disease (FMD)
Foot & Mouth Disease (FMD) vaccines contribute approximately 23% of global veterinary vaccines market revenue in 2022. These vaccines are critical for controlling outbreaks in livestock, particularly cattle, sheep, and goats. The rising emphasis on animal health and trade safety supports growth in this segment.
Newcastle Disease
Newcastle Disease vaccines hold an estimated 19% share of the global veterinary vaccines market. This highly contagious disease affects poultry worldwide, driving the need for effective preventive solutions. Rising global poultry production and increased vaccination programs fuel this segment's growth.
Porcine Reproductive & Respiratory Syndrome (PRRS)
PRRS vaccines account for around 15% of the global veterinary vaccines market. They are essential for preventing economic losses in swine farming due to respiratory issues and reproductive failures. The increasing focus on biosecurity and herd health management supports demand.
Canine Parvovirus
Canine Parvovirus vaccines contribute approximately 12% of global veterinary vaccines market revenue. These vaccines are critical for protecting puppies and adult dogs against severe gastrointestinal disease. The growing trend of pet ownership and rising veterinary care expenditure support this segment.
Brucellosis
Brucellosis vaccines hold an estimated 10% share of the global veterinary vaccines market. These vaccines help control zoonotic diseases affecting livestock and humans. Increasing livestock health initiatives and global efforts to reduce zoonotic transmission contribute to market growth.
Avian Influenza
Avian Influenza vaccines account for around 8% of the global veterinary vaccines market. These vaccines play a critical role in poultry health management and pandemic preparedness. The rising incidence of avian influenza outbreaks and growing global poultry industry support growth in this segment.
Others
The "Others" category, including vaccines for rabies, leptospirosis, and clostridial diseases, holds an estimated 13% share of the global veterinary vaccines market. These vaccines provide essential protection for companion animals and livestock and support diversification of veterinary vaccine portfolios.
Veterinary Vaccines Market, Segmentation by Distribution Channel
The Veterinary Vaccines Market has been segmented by Distribution Channel into Veterinary Hospital Pharmacies, Veterinary Clinics, Retail Pharmacies and Online Pharmacies.
Veterinary Hospital Pharmacies
Veterinary Hospital Pharmacies dominate the veterinary vaccines market, contributing approximately 42% of global revenue in 2022. These pharmacies ensure timely access to a broad range of veterinary vaccines and provide clinical support for specialized treatments. The rising focus on preventive healthcare for animals supports growth in this segment.
Veterinary Clinics
Veterinary Clinics hold an estimated 32% share of the global veterinary vaccines market. Clinics offer routine vaccination services for companion animals and livestock, enhancing animal health management. The growing trend of regular pet check-ups and herd health programs supports this segment's expansion.
Retail Pharmacies
Retail Pharmacies contribute around 16% of the global veterinary vaccines market. These outlets provide accessible vaccination products for pet owners and farmers, including over-the-counter vaccines and supportive care solutions. The increasing preference for convenient purchasing options supports growth.
Online Pharmacies
Online Pharmacies account for approximately 10% of the global veterinary vaccines market. The growing demand for home delivery of veterinary vaccines, rising adoption of e-commerce platforms, and the convenience of online ordering contribute to this segment’s rapid growth.
Veterinary Vaccines Market, Segmentation by Geography
In this report, the Veterinary Vaccines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Veterinary Vaccines Market Share (%), by Geographical Region
North America
North America leads the veterinary vaccines market, contributing approximately 39% of global revenue in 2022. The region benefits from advanced veterinary infrastructure, high pet ownership rates, and strong awareness of preventive care. Increasing investments in animal health and the presence of key market players drive market growth.
Europe
Europe holds around 28% of the global veterinary vaccines market. The region’s growth is driven by stringent animal health regulations, rising pet adoption, and growing livestock industry. Collaborative efforts between governments and animal health organizations further fuel expansion.
Asia Pacific
Asia Pacific accounts for an estimated 21% share of the global veterinary vaccines market. Factors such as rapid urbanization, growing pet ownership, increasing livestock population, and rising awareness of animal health contribute to strong regional growth. Countries like China, Japan, and India are key contributors.
Middle East and Africa
Middle East and Africa contribute approximately 7% of the global veterinary vaccines market. Expanding veterinary services, increasing focus on livestock health, and rising government initiatives to improve animal welfare support growth in this region. Collaborations with global market players enhance potential.
Latin America
Latin America holds around 5% of the global veterinary vaccines market. Growth is driven by rising veterinary care expenditure, expanding livestock industry, and increasing adoption of companion animals. Regional efforts to improve animal health and strengthen veterinary services support market expansion.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Veterinary Vaccines Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Prevalence of Infectious Diseases in Animals
- Growing Demand for Animal Protein Products
-
Rising Awareness of the Importance of Vaccination - Veterinarians play a pivotal role in educating animal owners and producers about the benefits of vaccination as a proactive measure to protect animal populations from disease outbreaks. With their expertise in veterinary medicine and infectious disease control, veterinarians advocate for vaccination as a fundamental component of preventive healthcare programs for animals. They provide guidance on vaccination schedules, vaccine selection, and proper vaccine administration techniques, empowering animal owners to make informed decisions about the health and well-being of their animals.
Animal owners and producers are becoming increasingly aware of the economic and productivity benefits associated with vaccination in livestock and poultry production. Vaccination helps reduce the incidence and severity of infectious diseases, minimizing production losses due to morbidity, mortality, and decreased performance in animals. By investing in vaccination programs, animal owners can improve herd health, enhance animal welfare, and optimize production efficiency, ultimately contributing to the profitability and sustainability of their operations.
Stakeholders in the animal health industry, including vaccine manufacturers, regulatory agencies, and professional associations, are actively involved in raising awareness about the importance of vaccination through educational campaigns, advocacy efforts, and industry initiatives. They promote evidence-based vaccination strategies, encourage adherence to best practices in vaccine development and administration, and support research and innovation in veterinary vaccinology to address emerging disease threats and evolving vaccination needs.
Restraints
- Regulatory Challenges and Approval Processes
- Limited Access to Veterinary Vaccines
-
Vaccine Storage and Distribution Challenges - One of the primary challenges related to vaccine storage is maintaining the cold chain, which involves storing vaccines within a specific temperature range to preserve their potency and efficacy. Many veterinary vaccines, particularly live attenuated and inactivated vaccines, are sensitive to temperature fluctuations and can lose their effectiveness if exposed to temperatures outside the recommended range. Maintaining the cold chain requires reliable refrigeration equipment, temperature monitoring devices, and adequate training of veterinary personnel to ensure proper storage and handling practices throughout the vaccine distribution process.
Inadequate infrastructure and logistical challenges in rural and remote areas can exacerbate vaccine storage and distribution challenges, particularly in developing regions with limited access to electricity, transportation, and healthcare facilities. In such areas, maintaining the cold chain becomes even more challenging, leading to vaccine wastage, reduced efficacy, and compromised disease control efforts.
Vaccine distribution logistics, including transportation, inventory management, and supply chain coordination, can pose significant hurdles in ensuring timely and equitable access to veterinary vaccines across different geographic regions. Poor road infrastructure, logistical bottlenecks, and inadequate distribution networks can result in delays, stockouts, and uneven vaccine coverage, hindering vaccination campaigns and compromising disease surveillance and control efforts.
Opportunities
- Development of Next-Generation Vaccines
- Expansion of Veterinary Vaccination Programs
-
Adoption of Companion Animal Vaccination - The adoption of companion animal vaccination represents a growing trend driven by several factors. Firstly, increased awareness among pet owners about the importance of preventive healthcare measures, including vaccination, has led to greater demand for companion animal vaccines. Pet owners recognize that vaccination is essential for protecting their pets from a myriad of infectious diseases that can compromise their health and longevity. As a result, veterinary professionals are witnessing a higher acceptance and compliance with vaccination recommendations for companion animals.
Advancements in veterinary vaccine technology have expanded the availability and efficacy of companion animal vaccines. Manufacturers are developing vaccines that offer broader protection against a range of pathogens, longer duration of immunity, and improved safety profiles. These advancements contribute to the overall effectiveness and acceptance of companion animal vaccination programs, encouraging pet owners to prioritize preventive healthcare for their furry companions.
The human-animal bond, characterized by the strong emotional and psychological connections between pet owners and their animals, drives the adoption of companion animal vaccination. Pet owners perceive vaccination as a proactive measure to safeguard their pets' health and well-being, thereby strengthening the bond between them and enhancing their overall quality of life.
The adoption of companion animal vaccination not only benefits individual pets but also contributes to public health by reducing the transmission of zoonotic diseases from animals to humans. Vaccinating companion animals against diseases such as rabies, leptospirosis, and feline leukemia not only protects the animals themselves but also helps prevent the spread of these diseases to humans, thereby promoting public health and safety.
Competitive Landscape Analysis
Key players in Global Veterinary Vaccines Market include:
- Zoetis Inc
- Merck & Co Inc
- Boehringer Ingelheim International GmbH
- Elanco Animal Health
- Virbac
- Ceva Santé Animale
- Phibro Animal Health Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Technology
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Veterinary Vaccines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Prevalence of Infectious Diseases in Animals
-
Growing Demand for Animal Protein Products
-
Rising Awareness of the Importance of Vaccination
-
- Restraints
-
Regulatory Challenges and Approval Processes
-
Limited Access to Veterinary Vaccines
-
Vaccine Storage and Distribution Challenges
-
- Opportunities
-
Development of Next-Generation Vaccines
-
Expansion of Veterinary Vaccination Programs
-
Adoption of Companion Animal Vaccination
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Veterinary Vaccines Market, By Type, 2021 - 2031 (USD Million)
-
Porcine
-
Poultry
-
Livestock
-
Companion Animals
-
- Veterinary Vaccines Market, By Technology, 2021 - 2031 (USD Million)
-
Live Attenuated
-
Inactivated
-
Toxoid
-
- Veterinary Vaccines Market, By Disease Indication, 2021 - 2031 (USD Million)
- Foot & Mouth Disease (FMD)
- Newcastle Disease
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Canine Parvovirus, Brucellosis
- Avian Influenza
- Others
- Veterinary Vaccines Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Veterinary Hospital Pharmacies
- Veterinary Clinics
- Retail Pharmacies
- Online Pharmacies
- Veterinary Vaccines Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Veterinary Vaccines Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Zoetis Inc
- Merck & Co Inc
- Boehringer Ingelheim International GmbH
- Elanco Animal Health
- Virbac
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market